Segui
Diego Useche
Diego Useche
Email verificata su u-bordeaux.fr
Titolo
Citata da
Citata da
Anno
Are patents signals for the IPO market? An EU–US comparison for the software industry
D Useche
Research Policy 43 (8), 1299-1311, 2014
792014
Highly skilled and well connected: Migrant inventors in cross-border M&As
D Useche, E Miguelez, F Lissoni
Journal of International Business Studies 51, 737-763, 2020
262020
Orphan drug designations as valuable intangible assets for IPO investors in pharma-biotech companies
P Gorry, D Useche
Economic Dimensions of Personalized and Precision Medicine, 305-334, 2018
112018
Patenting behaviour and the survival of newly listed European software firms
D Useche
Industry and Innovation 22 (1), 37-58, 2015
102015
Where do we go? VC firm heterogeneity and the exit routes of newly listed high-tech firms
D Useche, S Pommet
Small Business Economics 57, 1339-1359, 2021
62021
Crowdfunding to overcome the liability of outsidership: Drivers of immigrant entrepreneurs’ fundraising performance
V Butticè, D Useche
Working Paper). Retrieved from https://conference. druid. dk/acc_papers …, 2018
42018
Crowdfunding to overcome the immigrant entrepreneurs’ liability of outsidership: the role of internal social capital
V Butticè, D Useche
Small Business Economics, 1-22, 2022
22022
Highly-skilled migrants and Cross-border M&A: Firm-level evidence
D Useche, E Miguelez, F Lissoni
Journal of International Business Studies 51, 737–763, 2020
2020
Crowdfunding to overcome the liability of outsidership Drivers of immigrant entrepreneurs’ fundraising performance. Paper to be presented at DRUID19 Copenhagen Business School …
V Buttice, D Useche
2019
Conveying quality or competitive advange? Evidence for heterogeneous VCs in newly-listed technology-based firms
D Useche, S Pommet
2018
Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies. NBER working paper n° w24021
P Gorry, D Useche
HAL, 2017
2017
Empirical Economic Analysis of Orphan Drug Innovation
P Gorry, D Useche, M Zumpe
HAL Post-Print, 2016
2016
Orphan Drug Designations as Valuable intangible assets for Ipo Investors in Pharma-biotech companies
D Useche, P Gorry
HAL Post-Print, 2015
2015
Les droits de la propriété Intellectuelle et les marchés financiers dans la stratégie des firmes du logiciel en Europe et aux Etats-Unis
D Useche
Bordeaux, 2014
2014
Call for Papers-The challenges and opportunities of high-skilled migration
V Butticè, D Useche
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–15